SORRENTO THERAPEUTICS, INC.

Basic Information

6042 CORNERSTONE CT, STE B
SAN DIEGO, CA, 92121-4746

http://www.sorrentotherapeutics.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 832545805
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 65


  1. Human Anti-WISP1 Antibodies for Treatment of Idiopathic Pulmonary Fbrosis

    Amount: $224,823.00

    DESCRIPTION (provided by applicant): New anti-fibrotic drugs are needed to treat Idiopathic Pulmonary Fibrosis (IPF). IPF is a progressive, chronically debilitating clinical syndrome with unknown etio ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Targeting of Myc-Max dimerization for the treatment of cancer

    Amount: $224,550.00

    DESCRIPTION (provided by applicant): Myc is a key transcriptional regulator due to its critical role in many fundamental cellular processes, such as cell cycle progression and cell growth. Therefore, ...

    STTR Phase I 2014 Department of Health and Human Services
  3. Anti-Pseudomonas Immunotherapy and Targeted Drug Delivery

    Amount: $586,535.00

    DESCRIPTION (provided by applicant): Antibody therapy for serious bacterial infections using polyclonal immune antitoxin or anti-capsule horse serum actually predates small molecule antibiotic use. Ho ...

    STTR Phase I 2014 Department of Health and Human Services
  4. Human monoclonal antibodies for prevention of S. aureus infections

    Amount: $1,997,627.00

    DESCRIPTION (provided by applicant): Using mouse monoclonal antibodies (mAbs) raised against the mediators of quorum sensing (QS), the Auto-Inducing Peptides (AIPs), researchers at The Scripps Researc ...

    STTR Phase II 2014 Department of Health and Human Services
  5. Human monoclonal antibodies for prevention of S. aureus infections

    Amount: $597,832.00

    DESCRIPTION (provided by applicant): Using mouse monoclonal antibodies (mAbs) raised against the mediators of quorum sensing (QS), the Auto-Inducing Peptides (AIPs), researchers at The Scripps Researc ...

    STTR Phase I 2012 Department of Health and Human Services
  6. A vaccine against Clostridium difficile infections

    Amount: $598,689.00

    DESCRIPTION (provided by applicant): In this proposal we lay out a comprehensive research plan to evaluate our vaccination strategies targeting Clostridium difficile to prevent or treat infections. W ...

    STTR Phase I 2011 Department of Health and Human Services
  7. Evaluation of Staphylococcus aureus agr-based Quorum Sensing as Vaccine Candidate

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): In this proposal we lay out a comprehensive research plan to evaluate our passive vaccination strategies targeting Staphylococcus aureus/MRSA to prevent or treat ...

    STTR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government